Company Overview and News


Add PANACEABIO
to your dashboard

Headline News

Panacea Biotec Limited - Corrigendum

2017-11-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Press Release

2017-11-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Market Live: Sensex extends losses, Nifty breaks 10,150; ONGC, Sun Pharma fall 3-4%

2017-11-15 moneycontrol
12:55 pm Market Update: Equity benchmarks extended losses amid volatility, tracking weak global cues after trade deficit data. (15-0)

Panacea Biotec, Cox Kings up 7-8% on strong Q2 numbers

2017-11-15 moneycontrol
Shares of Panacea Biotec and Cox & Kings rose 7-8 percent intraday Wednesday on the back strong September quarter (Q2FY18) numbers.

Market Live: Sensex opens below 33K, Nifty mildly lower; Sun Pharma, Vedanta dip 2%

2017-11-15 moneycontrol
10:32 am Market Check: Benchmark indices as well as broader markets continued to trade mildly lower, weighed by weak global cues. Metals, FMCG, oil & gas exploration and HDFC Group stocks were under pressure. (6-0)

Panacea Biotec Limited - Updates

2017-10-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Shareholders meeting

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec says ANDA of Prasugrel approved by US FDA

2017-10-24 business-standard
Drug firm Panacea Biotec on Tuesday said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for preventing blood clots in people with acute coronary syndrome, in the American market. The company is also entitled for 180 days of shared market exclusivity for the Prasugrel HCL tablets, it added.

Panacea Biotec gets USFDA nod to launch Prasugrel tablets

2017-10-24 thehindubusinessline
Drug firm Panacea Biotec today said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for preventing blood clots in people with acute coronary syndrome, in the American market.

Panacea Biotec gets USFDA nod to launch Prasugrel tablets

2017-10-24 moneycontrol
Drug firm Panacea Biotec today said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for preventing blood clots in people with acute coronary syndrome, in the American market.

Panacea shares rise 14% on generic drug launch in US

2017-10-24 moneycontrol
Panacea Biotec's shares rose 14 percent on Tuesday, as the company announced the launch of the generic version of anti-platelet medication Prasugrel 5mg and 10mg tablets in US.

Panacea Biotec surges 15% on getting USFDA approval

2017-10-24 indiainfoline
The product has been launched in the market by Apotex Corp., the largest Canadian-owned pharmaceutical company which is the exclusive sales and distribution partner for this product in the US.

Panacea Biotec Limited - Press Release

2017-10-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Press Release

2017-10-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

This week in pharma: Quiet Diwali for stocks as analysts predict challenging Q2

2017-10-21 moneycontrol
Pharma stocks this Diwali week were largely quiet as analysts remained mixed in their view on Q2 estimates with many predicting a challenging quarter for drug makers. Major pharma companies will start reporting Q2 numbers from the next week. (2-0)